Biodistribution and Dosimetry of Ga-68 P16-093 in Prostate Cancer
Biodistribution and Dosimetry of Ga-68 P16-093 in Prostate Cancer
Active, not recruiting · NCT03444844 · Registry updated 2022-05-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Biodistribution and Dosimetry of Ga-68 P16-093 in Prostate Cancer | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Active, not recruiting | Phase 1 / Phase 2 | 2022-05-02 | NCT03444844 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Five Eleven Pharma, Inc. | 2 |
| Indiana University | 297 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Goodman Hall, Indiana Institute for Biomedical Imaging Sciences, Indiana University School of Medicine | Indianapolis | United States | 2 |